Spruce Biosciences

Investment area

Venture Investments

Region

North America

Date of investment

March 2016

Spruce Biosciences is a clinical-stage biopharmaceutical company with programs in development to serve the chronic and acute needs of patients with orphan disease affecting the neuro-endocrine axis.

Visit site